Skip to content

Author

Yufei Yang

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access 2026

Ferroptosis, cuproptosis, and metal ion-modulated cytotoxicity in osteosarcoma: regulatory mechanisms and emerging therapeutic strategies.

Osteosarcoma is characterized by early metastatic potential, frequent postoperative recurrence, and resistance to conventional chemotherapy, and therapeutic progress remains limited. Osteosarcoma may have exploitable vulnerabilities due to metal homeostasis and redox control dysregulation. However, metal-associated cyt...

Xue-Hai Liu, Lin-Zhu Li, Yu-Fei Yang et al. · 0 citations
Review Open access Oct 2026

Targeting ferroptosis in major digestive system malignancies: regulatory networks and therapeutic opportunities

Ferroptosis is an iron-dependent form of regulated cell death that is associated with the accumulation of lipid peroxides, particularly in polyunsaturated fatty acids (PUFAs)-containing cellular membranes. Ferroptosis is initiated by aberrant iron metabolism, intense reactive oxygen species (ROS) production, oxidativ...

Xiao-Guang Qin, Qing Wen, Yu-Fei Yang et al. · 0 citations
Review Open access Sep 2026

The silent dialogue between cells: regulatory roles of non-coding RNAs in cardiovascular disease

Non-coding RNAs (ncRNAs) are involved in the occurrence, progression, and repair of cardiovascular disease By post-transcriptional regulation, epigenetic modification, cell-fate determination, and metabolic homeostasis-related pathways, microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) reg...

Zhong-Wen Zhang, Yu-Fei Yang, Meng-Zhen Liu et al. · 0 citations
Open access Aug 2026

Pan‐Cancer Multi‐Omics Analysis Reveals the Potential of ZDHHC16 in Tumor Progression and Immune Regulation

The findings reveal that ZDHHC16 dysregulation is tissue‐specific and promotes tumor progression and modulates immune responses, highlighting its potential as a therapeutic target in several cancers, including ACC and BRCA.

Hao-Long Zhang, Sen-Yan Wu, Yufei Ma et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.